Category Archives: Opportunities

Job Alert: HR Generalist at Ulthera

Posted on by

ulthera-logo

Company: Ulthera, Inc.

Position: Human Resources Generalist

Job Description:

Ulthera is continuing to grow and has an immediate need for a Generalist with experience in Recruiting.

We would strongly prefer someone who has worked in the healthcare segment and/or someone who has worked in an environment with very little direction/process (we are in late stage start-up so people have to be able to find their own answers and just “make it work”).

The pace at Ulthera is incredibly fast with project prioritization being a required skill based on too much to do and not enough time being a standard scenario.  Our purpose-driven culture dictates the need for someone who is kind, ethical and very sharp.

This should be someone who people easily connect with and confide in while still being process oriented enough to get every spreadsheet and task completed meticulously.

It’s a tall order, it always is when you are looking for the best!

Contact Ulthera if you know of anyone who might be a fit and feel free to pay this forward and pass it on!

Who to contact: Stacie Mallen s.mallen@ulthera.com OR  Leticia Gastelum l.gastelum@ulthera.com

Career site: careers.ultherapy.com/

Job Alert: Clinical Coordinator/Technical Writer at VisionGate

Posted on by

Clinical Coordinator/Technical Writer

VisionGate Corporation

275 N. Gateway Dr. Phoenix, AZ  85034

VisionGate

 

VisionGate produces the Cell-CT™, the world’s first 3D cellular imaging device based upon optical projection tomography, which renders cells with sub-micron, isometric resolution. Based on 3D images of cells from sputum, VisonGate aims to improve patient health with the world’s first, non-invasive, diagnostic test for early lung cancer detection: LuCED™.  VisionGate is expanding its team in Phoenix that will carry the development and commercialization of its products forward.

 

Position Summary

VisionGate is currently commercializing its LuCED test for early detection of lung cancer.  We are also partnering with several institutions locally and internationally who will supply study specimens that will be used to evaluate the LuCED test.  Development of other tests based on the Cell-CT are being considered or are in progress.  To facilitate our development and clinical programs we seek to add a staff member who will coordinate these clinical studies.  Responsibilities will also involve creation of clinical study protocols and reports, abstracts for publications, and other documentation required in a regulated environment.  The position will report to the VisionGate CTO and may develop into a management role.  Some travel may be required.

 

Roles and Responsibilities

  • Identify clinical sites who could supply VisionGate with specimens for its development and clinical programs.
  • Coordinate work with clinical sites that supply specimens for trials of VisionGate tests.
  • Maintain clinical study files.
  • Maintain inventory of specimens.
  • Insure commitments made in protocols have been fulfilled.
  • Aid writing study protocols.
  • Aid writing test reports and publications.

 

Training and Experience

  • BS in biology or other science-related major.
  • 5 years experience as a clinical study coordinator.
  • 2-3 years experience as a technical/clinical writer.
  • Status as an author in a peer-reviewed journal desired.
  • Excellent oral communications skills.
  • Familiarity with CLIA regulations.
  • Familiarity with FDA GCP and HSP regulations.
  • Experience with operation in an FDA regulated environment.

 

To apply contact Michael Meyer, meyer@visiongate3d.com

Job Alert: IT Support Engineer at VisionGate

Posted on by

IT Support Engineer

VisionGate Corporation

275 N. Gateway Dr. Phoenix, AZ  85034

 

VisionGate

 

 

 

VisionGate produces the Cell-CT™, the world’s first 3D cellular imaging device based upon optical projection tomography, which renders cells with sub-micron, isometric resolution. Based on 3D images of cells from sputum, VisonGate aims to improve patient health with the world’s first, non-invasive, diagnostic test for early lung cancer detection: LuCED™.  VisionGate is expanding to carry the development and commercialization of its products forward.

 

Position Summary

VisionGate is currently commercializing its LuCED test for early detection of lung cancer.  Development of other tests based on the Cell-CT are being considered or are in progress.  To facilitate commercialization of our tests and manage our research IT environment, we seek to add a part-time staff member who will help manage and grow our IT Infrastructure.

 

 

Roles and Responsibilities

  • Manage in-house servers, update servers as in-house software is released.
  • Monitor and troubleshoot networking issues including phone system.
  • Manage backups and restores from tapes
  • Act as IT helpdesk for in-house and remotely based employees
  • Specifying and ordering new IT equipment
  • Documentation of procedures

 

 

Training and Experience

  • Experience with managing  Linux / Windows servers
  • Experience with networking.
  • Experience with phone system a plus, though not necessary.
  • Perl or Python programming a plus, though not necessary.
  • Excellent written and oral communications skills.
  • Strong team and interpersonal skills.

 

To apply contact Rahul Katdare, katdare@visiongate3d.com

Job Alert: Senior Research Development and Commercialization Associate at NAU

Posted on by

NAU_PrimV_webCompany:

Northern Arizona University

Position:

Senior Research Development and Commercialization Associate

Job Description:

The Senior Research Development and Commercialization Associate is charged with sourcing, building and maintaining strong, productive relationships with faculty, staff and student researchers and innovators-as well as with existing/prospective licensees, industry partners, entrepreneurs, and the local, regional and national innovation management community-for the purpose of catalyzing research and technology development and pushing university innovations from the lab to the marketplace.  The Senior Research Development and Commercialization Associate participates in decision-making associated with institutional-level research investments and also manages an assigned portfolio of technologies from initial invention disclosure through the commercial life of the technologies.  Reports to the Chief of Staff, Office of the Vice President for Research and Director of NAU Innovations (one individual).

 

To learn more and apply, please click here.

Tallwave expands competition to include Health IT

Posted on by
Tallwave today announced it is opening applications in its latest High Tide(TM) competition to Healthcare IT entrepreneurs from across the country. These entrepreneurs will join peers applying for the program in the previously announced focus on innovations in Ed Tech. In addition, Tallwave has reserved four to six slots for Arizona-only IT companies regardless of the industry sector they hail from. The deadline for submission is March 31, 2014 and can be completed online at www.tallwavehightide.com .Continue reading→

Opportunity Alert – AZ Fast Grants 2014

Posted on by

ACA_HorzCMYK

The AZ Fast Grant competition

will open on Monday, March 10!

 

 

This competitive grant enables Arizona-based technology companies to initiate the commercialization process. Total funds available for this grant round are $175,000.

 

Maximum awards of $5,000 and $20,000 will enable companies to accomplish one of four scopes of work.

 

  1. SBIR/STTR Proposal Development (Maximum award $5,000)
  • Awardees will be automatically enrolled in our PIII Playbook training class with 23 hours of training and coaching. Cost per company to participate is $1,500. This will be paid from the AZ Fast Grant award. Services will be provided by consultants under contract with ACA.
  • We are providing an additional $3,500 to the awardee for SBIT/STTR proposal writing assistance. The awardee may hire any professional consultant to assist them.

 

  1. Commercialization Feasibility Study (Maximum award $5,000)  The awardee may hire any professional consultant to assist them.
  • Identify show stoppers to commercialization before resources are spent commercializing a technology that is unlikely to succeed.

 

  1. Other Acceptable Means of Technology Commercialization Assistance (Maximum award $5,000) The awardee may hire any professional consultant to assist them.
  • Technology Review – An expert review of the technology under development to determine if it already exists, is a good candidate for intellectual property protection and is likely to find an attractive market.
  • Requests for other acceptable means of technology commercialization assistance will be considered.

 

  1. Innovation in Manufacturing (Maximum award $20,000)
  • This award provides seed monies for the creation and proof of concept testing of disruptive tools and technologies to Arizona manufacturing firms in targeted business sectors.
  • Commercialization of these tools and technologies is our top goal.
  • Solution providers, i.e. – consultants, training firms, engineering and technology companies, and educational institutions, are required to team with manufacturers to submit proposals.
  • Each proposer must identify a teaming arrangement with Arizona manufacturers. Preference will be given to proposers teaming with multiple manufacturing partners.
  • Applicants and their manufacturing partners must leverage the award funds with a partial match of the requested award amount.
  • Applicants must demonstrate a 50% match (cash and in-kind) of the requested award amount. Preference will be given to applicants with higher cash to in-kind ratio.
  • Manufacturing partners must provide a total award match of at least 25% cash and/or in-kind, i.e. – labor, materials, machine time, plant overhead, etc. Preference will be given to applicants with higher industry in-kind contributions.
  • Match requirements for a theoretical award might look like:

 

Innovation in Manufacturing Award          $20,000

Proposer Match (50%)                            $10,000

Sub Total                                   $30,000

Total of Manufacturing Partners’ Match (25%)  $7,500

Total Grant Value                                          $37,500

 

Important Details

  • Applications must be completed on-line via the link on the AZ Fast Grant webpage .  
  • Closes on April 14 @ 5pm MST.
  • Awards will be announced in June.

NCI SBIR Direct to Phase II Pilot Program

Posted on by

Direct to Phase II Pilot Program is here!
Jump Into New Funding Opportunities Now

Finding funding to continue your innovative cancer research can be difficult. Luckily, there’s some good news.

The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center is implementing the SBIR Direct to Phase II Pilot solicitation, PAR-14-088, per the 2011 SBIR & STTR Reauthorization Act, allowing applicants that have demonstrated the R&D and technical merit characteristic of a Phase I (R43) SBIR project to bypass Phase I and apply directly for SBIR Phase II grants.

We encourage you to review the opportunity below and consider applying.

 


Direct Phase II Pilot Program

The NCI SBIR Development Center welcomes qualified applicants to participate in the newly authorized Direct-to-Phase II SBIR grant mechanism. This program applies to SBIR only, NOT STTR.This program is designed to expand opportunities for small business concerns and accelerate the pace of technology development and commercialization. Applicants that have demonstrated the R&D and technical merit characteristic of a Phase 1 (R43) SBIR project are encouraged to apply.

Standard deadlines apply. The next application receipt date is April 5, 2014, 5:00PM local time.

 


NIH SBIR and STTR applicants may now switch programs at Phase II or Phase IIB

  • Applicants may now switch between SBIR & STTR Programs. Those who previously were funded under an STTR Phase I award are now eligible to apply for an SBIR Phase II award and vice versa.
  • Those who previously were funded under an STTR Phase II award are now eligible to apply for an SBIR Phase IIB award and vice versa.

View the Application Guide for NIH and Other PHS Agencies for more information on preparing and submitting SBIR & STTR applications.

 


Recently ReleasedThe SBIR Phase IIB Bridge Award RFA is now live. Please apply by April 21, 2014, 5:00PM local time.

How to Apply
For resources and examples of SBIR grant applications and contract proposals, please visit http://sbir.cancer.gov/resource/apply/.

Please visit http://sbir.cancer.gov/ to learn more about the NCI SBIR & STTR Programs.

The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov